(NYSE: QGEN) Qiagen Nv's forecast annual revenue growth rate of 7.93% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 7.86%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.58%.
Qiagen Nv's revenue in 2026 is $2,070,781,000.On average, 26 Wall Street analysts forecast QGEN's revenue for 2026 to be $489,355,880,000, with the lowest QGEN revenue forecast at $460,403,775,000, and the highest QGEN revenue forecast at $514,607,340,000. On average, 21 Wall Street analysts forecast QGEN's revenue for 2027 to be $519,831,780,000, with the lowest QGEN revenue forecast at $485,655,235,000, and the highest QGEN revenue forecast at $551,396,105,000.
In 2028, QGEN is forecast to generate $574,035,345,000 in revenue, with the lowest revenue forecast at $512,430,490,000 and the highest revenue forecast at $709,217,730,000.